Geriatrics
Latest News
Can this device take on enlarged prostates?
“I think this is something that a lot of people are going to be able to use in their practice and that their patients are going to benefit from,”...
Latest News
Is this the best screening test for prostate cancer?
Researchers from the United Kingdom found that half of men with apparently “safe” PSA levels had clinically significant prostate cancers when...
Latest News
Treating fractures in elderly patients: Beyond the broken bone
Osteoporosis management can prevent fractures, and follow-up after fractures can prevent future breaks.
From the Journals
Osteoarthritis cases projected to balloon over next 30 years
In “a major challenge to health systems,” osteoarthritis may affect nearly 1 billion people in 2050.
Commentary
The most important study from ESC: FRAIL-AF
This is the kind of science that medicine should celebrate. There were no soft endpoints, financial conflicts, or spin.
Latest News
Weight loss linked to mortality risk in older women
Women whose 5% or greater weight loss was unintentional were even less likely to survive to older age.
Latest News
Could retinal changes be a harbinger of Parkinson’s?
“I think we are still several years away from converting these findings into individual level prediction for patients.”
From the Journals
Dementia diagnosis a good time to reduce polypharmacy
Time of diagnosis can be a potential inflexion point for deprescribing long-term medications with safety risks, limited benefit, or possible...
Latest News
Most with early AD not eligible for new antiamyloid drugs
Older patients aren’t eligible largely because of the presence of medical conditions or neuroimaging findings.
Highlights
American Geriatrics Society 2023 updated Beers Criteria highlights
The guidelines address safe prescribing of medications to older adults after review of 1,500 clinical trials and research studies.
From the Journals
Few meet eligibility for newer Alzheimer’s drugs
Fewer than 10% of early Alzheimer’s patients in a real-world cohort would qualify for trials of anti–amyloid-beta monoclonal antibodies, a study...